MENU

CTNM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Contineum Therapeutics (CTNM) Ownership - Who owns Contineum Therapeutics?

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

3565 General Atomics Court

Phone

+1 858 333-5280

Employees

51

Web

https://www.contineum-tx.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

432.93M

P/E Ratio

26.40

Total Cash

246.33M

Projected Growth

N/A

Total Debt

6.95M

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

6.59

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+18%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CTNM

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CTNM

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details

Industry

N/A

Address

3565 General Atomics Court

Phone

+1 858 333-5280

Employees

51

Web

https://www.contineum-tx.com